ADAMTSL5 and psoriasis: Future research should focus on exploring immune tolerance induction as a novel treatment approach, particularly through antigen-specific immunotherapy targeting psoriasis-associated autoantigens such as K17 [60,171] and ADAMTSL5 [51,273].